626 Shares in Teleflex Incorporated (NYSE:TFX) Acquired by Opal Wealth Advisors LLC

Opal Wealth Advisors LLC bought a new stake in shares of Teleflex Incorporated (NYSE:TFX) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 626 shares of the medical technology company’s stock, valued at approximately $142,000.

Several other hedge funds have also recently added to or reduced their stakes in the business. Bridge Creek Capital Management LLC lifted its position in shares of Teleflex by 2.7% in the first quarter. Bridge Creek Capital Management LLC now owns 16,263 shares of the medical technology company’s stock worth $3,678,000 after buying an additional 430 shares during the last quarter. Mather Group LLC. bought a new stake in Teleflex during the 1st quarter worth approximately $59,000. Rowlandmiller & PARTNERS.ADV boosted its position in Teleflex by 2.0% in the 1st quarter. Rowlandmiller & PARTNERS.ADV now owns 8,938 shares of the medical technology company’s stock valued at $2,022,000 after buying an additional 175 shares during the last quarter. Nomura Holdings Inc. bought a new position in shares of Teleflex in the 4th quarter worth $237,000. Finally, PNC Financial Services Group Inc. boosted its position in shares of Teleflex by 6.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 18,089 shares of the medical technology company’s stock worth $4,510,000 after purchasing an additional 1,018 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on TFX shares. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Friday, May 3rd. Truist Financial dropped their price target on shares of Teleflex from $240.00 to $219.00 and set a “hold” rating for the company in a research report on Friday, May 3rd. Four research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Teleflex presently has a consensus rating of “Moderate Buy” and an average price target of $257.29.

Teleflex Trading Up 0.7 %

Shares of TFX opened at $203.40 on Monday. The firm’s 50-day moving average price is $208.37 and its 200-day moving average price is $227.11. The firm has a market capitalization of $9.58 billion, a price-to-earnings ratio of 32.65, a PEG ratio of 1.96 and a beta of 1.16. The company has a current ratio of 2.51, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1-year low of $177.63 and a 1-year high of $262.97.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, May 2nd. The medical technology company reported $3.21 EPS for the quarter, topping the consensus estimate of $3.07 by $0.14. The business had revenue of $737.80 million for the quarter, compared to analyst estimates of $726.85 million. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. Teleflex’s quarterly revenue was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.09 earnings per share. Sell-side analysts anticipate that Teleflex Incorporated will post 13.75 EPS for the current year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 14th. Shareholders of record on Wednesday, May 15th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Tuesday, May 14th. This represents a $1.36 dividend on an annualized basis and a yield of 0.67%. Teleflex’s dividend payout ratio is currently 21.83%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.